Indications and uses
helps prevent sunburn if used as directed with other sun protection measures (see Directions ), decreases the risk of skin cancer and early skin aging caused by the sun
RE9 Advanced ® LIFTING AND CONTOURING CREAM BROAD SPECTRUM SPF 15 SUNSCREEN
- Manufacturer
- Arbonne International, LLC
- Effective date
- 2022-12-09
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 5
- Source
- legacy-cache
- Hydrated at
- 2026-08-01 21:44:42
Label at a glance#
ProductRE9 Advanced LIFTING AND CONTOURING BROAD SPECTRUM SPF 15 SUNSCREEN
Active ingredientZINC OXIDE
Label structure11 sections
Dosage and administration
For sunscreen use: apply liberally 15 minutes before sun exposure reapply at least every 2 hours use a water-resistant sunscreen if swimming or sweating Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a broad spectrum SPF value of 15 or higher and other sun protection measures including: limit time in t...
Storage and handling
protect the product in this container from excessive heat and direct sun
Contacts and useful links#
Label contents#
Full prescribing information#
SPL UNCLASSIFIED SECTION
Drug Facts
Active ingredient
Zinc Oxide 4.45%
Purpose
Sunscreen
Uses
- helps prevent sunburn
- if used as directed with other sun protection measures (see Directions), decreases the risk of skin cancer and early skin aging caused by the sun
Warnings
For external use only
OTC - DO NOT USE SECTION
Do not use on damaged or broken skin
OTC - WHEN USING SECTION
When using this product keep out of eyes. Rinse with water to remove.
OTC - STOP USE SECTION
Stop use and ask a doctor if rash occurs
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children.
If swallowed, get medical help or contact a Poison Control Center right away.
Directions
For sunscreen use:
- apply liberally 15 minutes before sun exposure
- reapply at least every 2 hours
- use a water-resistant sunscreen if swimming or sweating
- Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a broad spectrum SPF value of 15 or higher and other sun protection measures including:
- limit time in the sun, especially from 10 a.m.–2 p.m.
- wear long-sleeved shirts, pants, hats, and sunglasses
- children under 6 months of age: ask a doctor
Other information
- protect the product in this container from excessive heat and direct sun
Inactive ingredients
water, C12-15 alkyl benzoate, glycerin, simmondsia chinensis (jojoba) seed oil, polyglyceryl-3 methylglucose distearate, cetyl alcohol, caprylic/capric triglyceride, cetyl dimethicone, cetyl palmitate, dimethicone, behenyl alcohol, cetearyl alcohol, glyceryl stearate, squalane, isononyl isononanoate, butyrospermum parkii (shea) butter, hydroxyethyl acrylate/sodium acryloyldimethyl taurate copolymer, hydroxyethylcellulose, xanthan gum, caprylyl glycol, sodium lauroyl glutamate, stearic acid, polysorbate 60, sorbitan isostearate, olea europaea (olive) fruit oil, hippophae rhamnoides oil, aloe barbadensis leaf juice, osmanthus fragrans flower extract, paeonia albiflora root extract, chondrus crispus extract, laminaria digitata extract, ganoderma lucidum (mushroom) stem extract, serenoa serrulata fruit extract, anthemis nobilis flower extract, cucumis sativus (cucumber) fruit extract, trifolium pratense (clover) flower extract, undaria pinnatifida extract, lithothamnion calcareum extract, tetrahexyldecyl ascorbate, panthenol, tocopheryl acetate, pantolactone, acetyl tetrapeptide-2, vinyl dimethicone/methicone silsesquioxane crosspolymer, micrococcus lysate, biosaccharide gum-1, disodium acetyl glucosamine phosphate, ethylhexylglycerin, citric acid, caprylhydroxamic acid, phytic acid, sodium citrate, sodium phosphate, disodium phosphate, aminomethyl propanediol, propanediol, triethoxycaprylylsilane, chlorphenesin, phenoxyethanol.
Questions or comments?
1.800.272.6663
Monday–Friday 6 a.m.–6 p.m. Pacific time
SPL UNCLASSIFIED SECTION
Distributed by
Arbonne International, LLC
9400 Jeronimo Road, Irvine, CA 92618 USA
PRINCIPAL DISPLAY PANEL - 50 g Jar Carton
ARBONNE®
RE9 ADVANCED®
LIFTING AND CONTOURING CREAM
BROAD SPECTRUM SPF 15 SUNSCREEN
Net wt. 1.7 oz. / 50 g
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 42508-079-08 | 2021-02-02 | C162847 | 48780-1 | ba0f9c33-4d09-a910-e053-dadaa90a0b85 | RE9 Advanced ® LIFTING AND CONTOURING CREAM BROAD SPECTRUM SPF 15 SUNSCREEN |
| 42508-079-11 | 2021-02-02 | C162847 | 48780-1 | ba0f9c33-4d09-a910-e053-dadaa90a0b85 | RE9 Advanced ® LIFTING AND CONTOURING CREAM BROAD SPECTRUM SPF 15 SUNSCREEN |
| 42508-079-08 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-4d09-a910-e053-dadaa90a0b85 | RE9 Advanced ® LIFTING AND CONTOURING CREAM BROAD SPECTRUM SPF 15 SUNSCREEN |
| 42508-079-11 | 2021-01-29 | C162847 | 48780-1 | ba0f9c33-4d09-a910-e053-dadaa90a0b85 | RE9 Advanced ® LIFTING AND CONTOURING CREAM BROAD SPECTRUM SPF 15 SUNSCREEN |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| ZINC OXIDE | ACTIVE INGREDIENT | SOI2LOH54Z | 1 | |
| ZINC OXIDE | ACTIVE MOIETY | SOI2LOH54Z | 1 | |
| .Alpha.-Tocopherol Acetate | INACTIVE INGREDIENT | 9E8X80D2L0 | 1 | |
| Alkyl (C12-15) Benzoate | INACTIVE INGREDIENT | A9EJ3J61HQ | 1 | |
| Aloe Vera Leaf | INACTIVE INGREDIENT | ZY81Z83H0X | 1 | |
| Aminomethyl Propanediol | INACTIVE INGREDIENT | CZ7BU4QZJZ | 1 | |
| Biosaccharide Gum-1 | INACTIVE INGREDIENT | BB4PU4V09H | 1 | |
| Caprylhydroxamic Acid | INACTIVE INGREDIENT | UPY805K99W | 1 | |
| Caprylyl Glycol | INACTIVE INGREDIENT | 00YIU5438U | 1 | |
| Cetostearyl Alcohol | INACTIVE INGREDIENT | 2DMT128M1S | 1 | |
| Cetyl Alcohol | INACTIVE INGREDIENT | 936JST6JCN | 1 | |
| Cetyl Dimethicone 25 | INACTIVE INGREDIENT | U4AS1BW4ZB | 1 | |
| Cetyl Hydroxyethylcellulose (350000 MW) | INACTIVE INGREDIENT | T7SWE4S2TT | 1 | |
| Cetyl Palmitate | INACTIVE INGREDIENT | 5ZA2S6B08X | 1 | |
| Chamaemelum Nobile Flower | INACTIVE INGREDIENT | O2T154T6OG | 1 | |
| Chlorphenesin | INACTIVE INGREDIENT | I670DAL4SZ | 1 | |
| Chondrus Crispus | INACTIVE INGREDIENT | OQS23HUA1X | 1 | |
| Citric Acid Monohydrate | INACTIVE INGREDIENT | 2968PHW8QP | 1 | |
| Cucumber | INACTIVE INGREDIENT | YY7C30VXJT | 1 | |
| Dexpanthenol | INACTIVE INGREDIENT | 1O6C93RI7Z | 1 | |
| Dimethicone | INACTIVE INGREDIENT | 92RU3N3Y1O | 1 | |
| Docosanol | INACTIVE INGREDIENT | 9G1OE216XY | 1 | |
| Ethylhexylglycerin | INACTIVE INGREDIENT | 147D247K3P | 1 | |
| Fytic Acid | INACTIVE INGREDIENT | 7IGF0S7R8I | 1 | |
| Ganoderma Lucidum Stem | INACTIVE INGREDIENT | U8PA41532G | 1 | |
| Glycerin | INACTIVE INGREDIENT | PDC6A3C0OX | 1 | |
| Glyceryl Monostearate | INACTIVE INGREDIENT | 230OU9XXE4 | 1 | |
| Glyoxal | INACTIVE INGREDIENT | 50NP6JJ975 | 1 | |
| Hippophae Rhamnoides Seed Oil | INACTIVE INGREDIENT | T53SBG6741 | 1 | |
| Hydroxyethyl Acrylate/Sodium Acryloyldimethyl Taurate Copolymer (45000 MPA.S at 1%) | INACTIVE INGREDIENT | 86FQE96TZ4 | 1 | |
| Isononyl Isononanoate | INACTIVE INGREDIENT | S4V5BS6GCX | 1 | |
| Jojoba Oil | INACTIVE INGREDIENT | 724GKU717M | 1 | |
| Laminaria Digitata | INACTIVE INGREDIENT | 15E7C67EE8 | 1 | |
| Medium-Chain Triglycerides | INACTIVE INGREDIENT | C9H2L21V7U | 1 | |
| Olive Oil | INACTIVE INGREDIENT | 6UYK2W1W1E | 1 | |
| Osmanthus Fragrans Flower | INACTIVE INGREDIENT | 4VA0BH57HU | 1 | |
| Paeonia Lactiflora Root | INACTIVE INGREDIENT | 3Z3866YW6P | 1 | |
| Pantolactone, (R)- | INACTIVE INGREDIENT | J288D7O0JS | 1 | |
| Phenoxyethanol | INACTIVE INGREDIENT | HIE492ZZ3T | 1 | |
| Polysorbate 60 | INACTIVE INGREDIENT | CAL22UVI4M | 1 | |
| Propanediol | INACTIVE INGREDIENT | 5965N8W85T | 1 | |
| Saw Palmetto | INACTIVE INGREDIENT | J7WWH9M8QS | 1 | |
| Sodium Citrate | INACTIVE INGREDIENT | 1Q73Q2JULR | 1 | |
| Sodium Lauroyl Glutamate | INACTIVE INGREDIENT | NCX1UU2D33 | 1 | |
| Sodium Nitrate | INACTIVE INGREDIENT | 8M4L3H2ZVZ | 1 | |
| Sorbitan Isostearate | INACTIVE INGREDIENT | 01S2G2C1E4 | 1 | |
| Squalane | INACTIVE INGREDIENT | GW89575KF9 | 1 | |
| Stearic Acid | INACTIVE INGREDIENT | 4ELV7Z65AP | 1 | |
| Tetrahexyldecyl Ascorbate | INACTIVE INGREDIENT | 9LBV3F07AZ | 1 | |
| Triethoxycaprylylsilane | INACTIVE INGREDIENT | LDC331P08E | 1 | |
| Trifolium Pratense Flower | INACTIVE INGREDIENT | 4JS0838828 | 1 | |
| Undaria Pinnatifida | INACTIVE INGREDIENT | ICV1OK7M1S | 1 | |
| Water | INACTIVE INGREDIENT | 059QF0KO0R | 1 | |
| Xanthan Gum | INACTIVE INGREDIENT | TTV12P4NEE | 1 |
Products#
Every source-derived product name is available through these pages.
- RE9 Advanced LIFTING AND CONTOURING BROAD SPECTRUM SPF 15 SUNSCREEN
- ZINC OXIDE
- Aloe Vera Leaf
- Aminomethyl Propanediol
- Chamaemelum Nobile Flower
- Docosanol
- Biosaccharide Gum-1
- Alkyl (C12-15) Benzoate
- Caprylhydroxamic Acid
- Medium-Chain Triglycerides
- Caprylyl Glycol
- Cetostearyl Alcohol
- Cetyl Alcohol
- Cetyl Dimethicone 25
- Cetyl Palmitate
- Chlorphenesin
- Chondrus Crispus
- Citric Acid Monohydrate
- Cucumber
- Dimethicone
- Ethylhexylglycerin
- Ganoderma Lucidum Stem
- Glycerin
- Glyceryl Monostearate
- Glyoxal
- Hippophae Rhamnoides Seed Oil
- Hydroxyethyl Acrylate/Sodium Acryloyldimethyl Taurate Copolymer (100000 Mpa.S At 1.5%)
- Isononyl Isononanoate
- Laminaria Digitata
- Olive Oil
- Osmanthus Fragrans Flower
- Paeonia Lactiflora Root
- Dexpanthenol
- Pantolactone, (R)-
- Phenoxyethanol
- Fytic Acid
- Polysorbate 60
- Propanediol
- Saw Palmetto
- Jojoba Oil
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 42508-079 | 42508-079-08, 42508-079-11 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Xanthan Gum | XANTHAN GUM | TTV12P4NEE | TABLET, ORALLY DISINTEGRATING / ORAL | 0.15 mg | ||
| Stearic Acid | STEARIC ACID | 4ELV7Z65AP | TABLET, ORALLY DISINTEGRATING / ORAL | 10 mg | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SHAMPOO, SUSPENSION / TOPICAL | 0.25 %w/v | ||
| Polysorbate 60 | POLYSORBATE 60 | CAL22UVI4M | SUPPOSITORY / RECTAL | 0.05 mg/mg | ||
| Polysorbate 60 | POLYSORBATE 60 | CAL22UVI4M | SUPPOSITORY / VAGINAL | 0.03 mg | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION, SOLUTION / INTRAMUSCULAR | 26 mg | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SWAB / TOPICAL | 0.05 %w/w | ||
| Cetyl Alcohol | CETYL ALCOHOL | 936JST6JCN | CAPSULE, DELAYED RELEASE / ORAL | 59 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | TABLET, CHEWABLE / ORAL | 12 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | DROPS / NASAL | 10 mg/1ml | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 225 mg | ||
| Polysorbate 60 | POLYSORBATE 60 | CAL22UVI4M | SUSPENSION / TOPICAL | 2.85 %w/w | ||
| Xanthan Gum | XANTHAN GUM | TTV12P4NEE | SOLUTION, GEL FORMING, EXTENDED RELEASE / OPHTHALMIC | 0.6 %w/w | ||
| Glyceryl Monostearate | GLYCERYL MONOSTEARATE | 230OU9XXE4 | TABLET / SUBLINGUAL | 1.23 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | AEROSOL / TOPICAL | 3 %w/w | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | CREAM / TOPICAL | 1720 mg | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / SUBCUTANEOUS | 28 mg | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL | 2 mg | ||
| Xanthan Gum | XANTHAN GUM | TTV12P4NEE | TABLET, FILM COATED / ORAL | 0.08 mg | ||
| Stearic Acid | STEARIC ACID | 4ELV7Z65AP | CAPSULE / ORAL | 90 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | CAPSULE, EXTENDED RELEASE / ORAL | 265 mg | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / INTRAMUSCULAR | 0.05 %w/v | ||
| .Alpha.-Tocopherol Acetate | .ALPHA.-TOCOPHEROL ACETATE | 9E8X80D2L0 | CAPSULE / ORAL | 2 mg | ||
| Glyceryl Monostearate | GLYCERYL MONOSTEARATE | 230OU9XXE4 | CREAM / VAGINAL | 140 mg | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION, POWDER, FOR SOLUTION / INTRAMUSCULAR | NA | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / INTRAVENOUS | 2068 mg | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION/ DROPS / OPHTHALMIC | 0.05 %w/v | ||
| Olive Oil | OLIVE OIL | 6UYK2W1W1E | SOLUTION / TOPICAL | 0.6 %w/w | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | LIQUID / ORAL | 2400 mg | ||
| Phenoxyethanol | PHENOXYETHANOL | HIE492ZZ3T | CREAM / TOPICAL | 57 mg | ||
| Xanthan Gum | XANTHAN GUM | TTV12P4NEE | FILM, SOLUBLE / ORAL | 1 mg | ||
| Cetyl Alcohol | CETYL ALCOHOL | 936JST6JCN | SUSPENSION / AURICULAR (OTIC) | 1 %w/v | ||
| Stearic Acid | STEARIC ACID | 4ELV7Z65AP | SOLUTION / TOPICAL | NA | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / INTRATHECAL | ADJ PH | ||
| Polysorbate 60 | POLYSORBATE 60 | CAL22UVI4M | SHAMPOO / TOPICAL | 14.55 %w/w | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION, CONCENTRATE / INTRAVENOUS | NA | ||
| Stearic Acid | STEARIC ACID | 4ELV7Z65AP | TABLET, DELAYED RELEASE / ORAL | 80 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION / TOPICAL | 1971 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION / NASAL | 25 mg/1ml | ||
| Squalane | SQUALANE | GW89575KF9 | SOLUTION / TOPICAL | 1 %w/w | ||
| Cetostearyl Alcohol | CETOSTEARYL ALCOHOL | 2DMT128M1S | SUPPOSITORY / VAGINAL | NA | ||
| Xanthan Gum | XANTHAN GUM | TTV12P4NEE | TABLET, EXTENDED RELEASE / ORAL | 528 mg | ||
| Stearic Acid | STEARIC ACID | 4ELV7Z65AP | AEROSOL, FOAM / TOPICAL | 8 %w/w | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / EPIDURAL | 0.02 %w/v | ||
| Cetostearyl Alcohol | CETOSTEARYL ALCOHOL | 2DMT128M1S | CREAM / TOPICAL | 1428 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION, CONCENTRATE / ORAL | 200 mg/1ml | ||
| Medium-Chain Triglycerides | MEDIUM-CHAIN TRIGLYCERIDES | C9H2L21V7U | POWDER, FOR SUSPENSION / ORAL | 3390 mg/5ml | ||
| Cetyl Alcohol | CETYL ALCOHOL | 936JST6JCN | TABLET, EXTENDED RELEASE / ORAL | 132 mg | ||
| Medium-Chain Triglycerides | MEDIUM-CHAIN TRIGLYCERIDES | C9H2L21V7U | INJECTION, EMULSION / INTRAVENOUS | 1.1 %w/v | ||
| Cetostearyl Alcohol | CETOSTEARYL ALCOHOL | 2DMT128M1S | TABLET, EXTENDED RELEASE / ORAL | 800 mg | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / INFILTRATION | 0.02 %w/v | ||
| Medium-Chain Triglycerides | MEDIUM-CHAIN TRIGLYCERIDES | C9H2L21V7U | TABLET, EXTENDED RELEASE / ORAL | 0.37 mg | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | EMULSION / TOPICAL | 0.11 %w/w | ||
| Stearic Acid | STEARIC ACID | 4ELV7Z65AP | TABLET, FILM COATED / ORAL | 176 mg | ||
| Glyceryl Monostearate | GLYCERYL MONOSTEARATE | 230OU9XXE4 | SUSPENSION / AURICULAR (OTIC) | 0.5 %w/v | ||
| Olive Oil | OLIVE OIL | 6UYK2W1W1E | LOTION / TOPICAL | 32468 mg | ||
| Medium-Chain Triglycerides | MEDIUM-CHAIN TRIGLYCERIDES | C9H2L21V7U | GEL / TOPICAL | 12 mg | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | CONCENTRATE / ORAL | 5.3 mg/1ml | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | FILM, EXTENDED RELEASE / TRANSDERMAL | 1.38 mg | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | CAPSULE, EXTENDED RELEASE / ORAL | 101 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 408f4711-2744-4c07-8b77-849d56b53bb8 | 1800d39c-ca3b-484c-9dab-5af30cd25045 | 2022-12-09 | Warnings | 408f4711-2744-4c07-8b77-849d56b53bb8 1800d39c-ca3b-484c-9dab-5af30cd25045 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.